Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
VRTX
VRTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest VRTX ETF News Today | Earnings, Events & Price Alerts
VRTX News
CRISPR Therapeutics: Potential and Challenges in Gene Editing
17h ago
Fool
CRISPR Therapeutics Faces Significant Challenges Amid Slow Rollout
17h ago
NASDAQ.COM
Vertex Pharmaceuticals Officer Plans to Sell $19.74 Million in Common Stock via Form 144
3d ago
moomoo
Healthcare Sector Outlook: CVS and Vertex Prospects
4d ago
Fool
CVS Health and Vertex Pharmaceuticals Outlook
4d ago
NASDAQ.COM
Investment Comparison: Centessa vs. Vertex Pharmaceuticals
4d ago
Fool
Crispr Therapeutics Rises 5% Amid Acquisition Speculation
4d ago
seekingalpha
Novo Nordisk Stock Plummets Amid Valuation Reset
5d ago
Benzinga
Vertex Pharmaceuticals: The Ultimate Biotech Stock to Buy Now
Feb 24 2026
Fool
Analysis of Vertex Pharmaceuticals' Future Growth Prospects
Feb 23 2026
NASDAQ.COM
Vertex Pharmaceuticals' Growth Outlook for the Next Decade
Feb 23 2026
Fool
CRISPR Therapeutics Shows Long-Term Investment Potential
Feb 20 2026
Fool
CRISPR Therapeutics Sees Stock Increase Following Earnings Report Amid Promising Pipeline Developments
Feb 19 2026
Marketbeat
CGUS Stock Performance Analysis and ETF Dynamics
Feb 18 2026
NASDAQ.COM
Vertex Pharmaceuticals Sustains Innovation and Growth Amid Market Challenges
Feb 18 2026
Fool
Vertex Pharmaceuticals Maintains Leadership in Cystic Fibrosis Treatment
Feb 18 2026
NASDAQ.COM
Show More News
